Matches in Nanopublications for { ?s ?p "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP804205.RAdpckP9DXdplxa3zBi1t8gJN0eBGgRwAwOa36iSO1moQ130_assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804205.RAdpckP9DXdplxa3zBi1t8gJN0eBGgRwAwOa36iSO1moQ130_provenance.
- NP328272.RAno42kodXYzk7Do-_HdOr-_7_bkawv4c8eGbZYVxtY8c130_assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328272.RAno42kodXYzk7Do-_HdOr-_7_bkawv4c8eGbZYVxtY8c130_provenance.
- NP710025.RAQCs-Z7kz4ybCgN8QgQfXyBkU4RTNbFOuC4m1wl27bcI130_assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710025.RAQCs-Z7kz4ybCgN8QgQfXyBkU4RTNbFOuC4m1wl27bcI130_provenance.
- assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP304102.RABAOZVBM3-Gqh8D0pebBwOcHdR23vQ-sUWfTOL2uGpUw130_assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304102.RABAOZVBM3-Gqh8D0pebBwOcHdR23vQ-sUWfTOL2uGpUw130_provenance.
- NP710020.RAAoolI1jyuOC2XCrb5rGAQ-trMQuK6V3Yas7TqRVmUnw130_assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710020.RAAoolI1jyuOC2XCrb5rGAQ-trMQuK6V3Yas7TqRVmUnw130_provenance.
- NP304103.RAMc2Cv1p-AYxN3W41JDWONUMSf0IoEZI1OVgGZCv4ZnQ130_assertion description "[Comparison of the mutation-positive group with the SPG4-excluded group revealed an older age at onset (p = 0.03), more disability (p = 0.001), more rapidly progressive paraparesis (p = 0.044), and more cognitive impairment (p = 0.024) among affected individuals with SPAST mutations, not confounded by disease duration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304103.RAMc2Cv1p-AYxN3W41JDWONUMSf0IoEZI1OVgGZCv4ZnQ130_provenance.